Index
1 Market Overview of Nanoparticles
1.1 Nanoparticles Market Overview
1.1.1 Nanoparticles Product Scope
1.1.2 Nanoparticles Market Status and Outlook
1.2 Global Nanoparticles Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nanoparticles Market Size by Region (2018-2029)
1.4 Global Nanoparticles Historic Market Size by Region (2018-2023)
1.5 Global Nanoparticles Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nanoparticles Market Size (2018-2029)
1.6.1 North America Nanoparticles Market Size (2018-2029)
1.6.2 Europe Nanoparticles Market Size (2018-2029)
1.6.3 Asia-Pacific Nanoparticles Market Size (2018-2029)
1.6.4 Latin America Nanoparticles Market Size (2018-2029)
1.6.5 Middle East & Africa Nanoparticles Market Size (2018-2029)
2 Nanoparticles Market by Type
2.1 Introduction
2.1.1 Liposomes
2.1.2 Polymer-Conjugated Drugs
2.1.3 Polymeric Nanoparticles
2.1.4 Dendrimers
2.1.5 Inorganic Nanoparticles
2.1.6 Others
2.2 Global Nanoparticles Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nanoparticles Historic Market Size by Type (2018-2023)
2.2.2 Global Nanoparticles Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nanoparticles Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nanoparticles Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nanoparticles Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nanoparticles Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nanoparticles Revenue Breakdown by Type (2018-2029)
3 Nanoparticles Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgery Centers
3.1.3 Diagnostic Centers
3.2 Global Nanoparticles Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nanoparticles Historic Market Size by Application (2018-2023)
3.2.2 Global Nanoparticles Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nanoparticles Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nanoparticles Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nanoparticles Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nanoparticles Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nanoparticles Revenue Breakdown by Application (2018-2029)
4 Nanoparticles Competition Analysis by Players
4.1 Global Nanoparticles Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanoparticles as of 2022)
4.3 Date of Key Players Enter into Nanoparticles Market
4.4 Global Top Players Nanoparticles Headquarters and Area Served
4.5 Key Players Nanoparticles Product Solution and Service
4.6 Competitive Status
4.6.1 Nanoparticles Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Nanoparticles Products, Services and Solutions
5.1.4 Novartis Nanoparticles Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Gilead Sciences
5.2.1 Gilead Sciences Profile
5.2.2 Gilead Sciences Main Business
5.2.3 Gilead Sciences Nanoparticles Products, Services and Solutions
5.2.4 Gilead Sciences Nanoparticles Revenue (US$ Million) & (2018-2023)
5.2.5 Gilead Sciences Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Nanoparticles Products, Services and Solutions
5.3.4 Johnson & Johnson Nanoparticles Revenue (US$ Million) & (2018-2023)
5.3.5 Amgen Recent Developments
5.4 Amgen
5.4.1 Amgen Profile
5.4.2 Amgen Main Business
5.4.3 Amgen Nanoparticles Products, Services and Solutions
5.4.4 Amgen Nanoparticles Revenue (US$ Million) & (2018-2023)
5.4.5 Amgen Recent Developments
5.5 Sigma-Tau Pharmaceuticals
5.5.1 Sigma-Tau Pharmaceuticals Profile
5.5.2 Sigma-Tau Pharmaceuticals Main Business
5.5.3 Sigma-Tau Pharmaceuticals Nanoparticles Products, Services and Solutions
5.5.4 Sigma-Tau Pharmaceuticals Nanoparticles Revenue (US$ Million) & (2018-2023)
5.5.5 Sigma-Tau Pharmaceuticals Recent Developments
5.6 Abraxis Biosciences
5.6.1 Abraxis Biosciences Profile
5.6.2 Abraxis Biosciences Main Business
5.6.3 Abraxis Biosciences Nanoparticles Products, Services and Solutions
5.6.4 Abraxis Biosciences Nanoparticles Revenue (US$ Million) & (2018-2023)
5.6.5 Abraxis Biosciences Recent Developments
5.7 Nano Interface Technology
5.7.1 Nano Interface Technology Profile
5.7.2 Nano Interface Technology Main Business
5.7.3 Nano Interface Technology Nanoparticles Products, Services and Solutions
5.7.4 Nano Interface Technology Nanoparticles Revenue (US$ Million) & (2018-2023)
5.7.5 Nano Interface Technology Recent Developments
6 North America
6.1 North America Nanoparticles Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nanoparticles Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nanoparticles Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nanoparticles Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nanoparticles Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nanoparticles Market Dynamics
11.1 Nanoparticles Industry Trends
11.2 Nanoparticles Market Drivers
11.3 Nanoparticles Market Challenges
11.4 Nanoparticles Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List